Fact CheckerSign in

NCT05939687RecruitingPhase 3

Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection

Prophylactic Mesh Placement During Temporary Stoma Closure: a Prospective Randomized Phase III Clinical Trial

Source: ClinicalTrials.gov · Last updated 7 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to compare the efficacy of using polypropylene mesh for hernia prevention after stoma closure in patients with colorectal cancer and non-mesh repair. The main question it aims to answer is: can mesh help prevent hernia? Participants will be divided into 2 groups: with and without mesh using. They must be followed up for 2 years after enrollment in the study. Researchers will compare mesh and non-mesh groups to evaluate the benefits and harms of mesh using in hernia prevention.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
142 (estimated)
First submitted
3 Jul 2023
Start date
5 Jun 2023
Primary completion date
1 Dec 2028
Lead sponsor
Blokhin's Russian Cancer Research Center
NCT number
NCT05939687

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 142
  • From 5 Jun 2023 to the primary completion date, 1 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Synchronous and metachronous malignant neoplasms
  • Clinically significant diseases of the cardiovascular system, liver, kidney, central nervous system
  • Parastomal inflammation and other conditions that increase the risk of postoperative complications
  • HIV infection

Other

  • Inability to obtain consent to participate
  • Pregnancy

Who the study is looking for

  • Signed informed consent
  • Absence of distant metastases (M0)
  • ECOG (Eastern Cooperative Oncology Group) status 0-2
  • completed course of adjuvant treatment
  • Absence of acute inflammatory parastomal complications
  • Integrity of colorectal anastomosis

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
N.N. Blokhin Russian Cancer Research Center
Coordinator of this site? Confirm its status
MoscowRussiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.